KEGG   PATHWAY: epz04934
Entry
epz04934                    Pathway                                
Name
Cushing syndrome - Equus przewalskii (Przewalski's horse)
Description
Cushing syndrome (CS) is a rare disorder resulting from prolonged exposure to excess glucocorticoids via exogenous and endogenous sources. The typical clinical features of CS are related to hypercortisolism and include accumulation of central fat, moon facies, neuromuscular weakness, osteoporosis or bone fractures, metabolic complications, and mood changes. Traditionally, endogenous CS is classified as adrenocorticotropic hormone (ACTH)-dependent (about 80%) or ACTH- independent (about 20%). Among ACTH-dependent forms, pituitary corticotroph adenoma (Cushing's disease) is most common. Most pituitary tumors are sporadic, resulting from monoclonal expansion of a single mutated cell. Recently recurrent activating somatic driver mutations in the ubiquitin-specific protease 8 gene (USP8) were identified in almost half of corticotroph adenoma. Germline mutations in MEN1 (encoding menin), AIP (encoding aryl-hydrocarbon receptor-interacting protein), PRKAR1A (encoding cAMP-dependent protein kinase type I alpha regulatory subunit) and CDKN1B (encoding cyclin-dependent kinase inhibitor 1B; also known as p27 Kip1) have been identified in familial forms of pituitary adenomas. However, the frequency of familial pituitary adenomas is less than 5% in patients with pituitary adenomas. Among ACTH-independent CS, adrenal adenoma is most common. Rare adrenal causes of CS include primary bilateral macronodular adrenal hyperplasia (BMAH) or primary pigmented nodular adrenocortical disease (PPNAD).
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
epz04934  Cushing syndrome
epz04934

Organism
Equus przewalskii (Przewalski's horse) [GN:epz]
Gene
103552470  CRH; corticotropin releasing hormone [KO:K05256]
103552912  CRHR1; corticotropin releasing hormone receptor 1 [KO:K04578]
103541706  corticotropin-releasing factor receptor 2-like [KO:K04579]
103565402  guanine nucleotide-binding protein G(s) subunit alpha [KO:K04632]
103547036  neuroendocrine secretory protein 55 [KO:K04632]
103550430  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]
103562505  adenylate cyclase type 2-like [KO:K08042] [EC:4.6.1.1]
103547823  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]
103561050  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]
103563830  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]
103563634  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]
103556685  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]
103565019  adenylate cyclase type 8-like [KO:K08048] [EC:4.6.1.1]
103567623  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]
103553014  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]
103557289  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]
103565953  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
103548908  CREB1; cAMP responsive element binding protein 1 [KO:K05870]
103553756  ATF2; activating transcription factor 2 [KO:K04450]
103565289  ATF4; activating transcription factor 4 [KO:K04374]
103566499  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]
103560297  CREB3; cAMP responsive element binding protein 3 [KO:K09048]
103564266  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]
103555399  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]
103549839  CREB5; cAMP responsive element binding protein 5 [KO:K09047]
103563297  ATF6B; activating transcription factor 6 beta [KO:K09049]
103559130  MEN1; menin 1 [KO:K14970]
103540554  ASH2L; ASH2 like histone lysine methyltransferase complex subunit [KO:K14964]
103561208  RBBP5; RB binding protein 5, histone lysine methyltransferase complex subunit [KO:K14961]
103548429  WDR5B; WD repeat domain 5B [KO:K14963]
103561602  WDR5; WD repeat domain 5 [KO:K14963]
103546689  KMT2A; lysine methyltransferase 2A [KO:K09186] [EC:2.1.1.354]
103552202  KMT2D; lysine methyltransferase 2D [KO:K09187] [EC:2.1.1.354]
103550643  CDKN2C; cyclin dependent kinase inhibitor 2C [KO:K06622]
103543581  CDKN2B; cyclin dependent kinase inhibitor 2B [KO:K04685]
103553644  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
103549196  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
103549440  RB1; RB transcriptional corepressor 1 [KO:K06618]
103541516  E2F1; E2F transcription factor 1 [KO:K17454]
103551301  E2F2; E2F transcription factor 2 [KO:K09389]
103549781  E2F3; E2F transcription factor 3 [KO:K06620]
103552141  guanine nucleotide-binding protein G(i) subunit alpha-1-like [KO:K04630]
103553052  GNAI3; G protein subunit alpha i3 [KO:K04630]
103557343  GNAI2; G protein subunit alpha i2 [KO:K04630]
103550950  AHR; aryl hydrocarbon receptor [KO:K09093]
103541609  neuronal PAS domain-containing protein 3-like [KO:K09093]
103550484  AIPL1; aryl hydrocarbon receptor interacting protein like 1 [KO:K17767]
103559991  AIP; aryl hydrocarbon receptor interacting protein [KO:K17767]
103547639  ARNT; aryl hydrocarbon receptor nuclear translocator [KO:K09097]
103552733  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]
103560212  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]
103556279  CCNE1; cyclin E1 [KO:K06626]
103567628  CCNE2; cyclin E2 [KO:K06626]
103564535  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]
103560754  voltage-dependent L-type calcium channel subunit alpha-1D [KO:K04851]
103543955  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]
103565109  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]
103549465  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]
103549616  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]
103549121  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]
103554952  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]
103547802  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]
103558687  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]
103555338  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]
103549630  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
103543290  dual specificity mitogen-activated protein kinase kinase 2-like [KO:K04369] [EC:2.7.12.2]
103547261  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
103562408  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
103561297  NR4A1; nuclear receptor subfamily 4 group A member 1 [KO:K04465]
103560128  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
103546936  USP8; ubiquitin specific peptidase 8 [KO:K11839] [EC:3.4.19.12]
103547816  POMC; proopiomelanocortin [KO:K05228]
103555005  MC2R; melanocortin 2 receptor [KO:K04200]
103542616  MRAP; melanocortin 2 receptor accessory protein [KO:K22398]
103546227  PDE8A; phosphodiesterase 8A [KO:K18437] [EC:3.1.4.53]
103547094  PDE8B; phosphodiesterase 8B [KO:K18437] [EC:3.1.4.53]
103565145  PDE11A; phosphodiesterase 11A [KO:K13298] [EC:3.1.4.17 3.1.4.35]
103559402  SP1; Sp1 transcription factor [KO:K04684]
103547337  PBX1; PBX homeobox 1 [KO:K09355]
103543718  cytochrome P450 11B1, mitochondrial-like [KO:K00497] [EC:1.14.15.4]
103558137  steroid 17-alpha-hydroxylase/17,20 lyase [KO:K00512] [EC:1.14.14.19 1.14.14.32]
103540556  STAR; steroidogenic acute regulatory protein [KO:K16931]
103546355  NCEH1; neutral cholesterol ester hydrolase 1 [KO:K14349] [EC:3.1.1.-]
103547256  ARMC5; armadillo repeat containing 5 [KO:K22499]
103561130  AGT; angiotensinogen [KO:K09821]
103558752  AGTR1; angiotensin II receptor type 1 [KO:K04166]
103553450  GNAQ; G protein subunit alpha q [KO:K04634]
103543382  guanine nucleotide-binding protein subunit alpha-11-like [KO:K04635]
103562440  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]
103559733  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]
103561633  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]
103542193  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]
103550297  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]
103546630  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]
103548182  inositol 1,4,5-trisphosphate receptor type 2-like [KO:K04959]
103564724  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
103559377  KCNK2; potassium two pore domain channel subfamily K member 2 [KO:K04913]
103549566  CACNA1G; calcium voltage-gated channel subunit alpha1 G [KO:K04854]
103565287  CACNA1I; calcium voltage-gated channel subunit alpha1 I [KO:K04856]
103541373  ORAI1; ORAI calcium release-activated calcium modulator 1 [KO:K16056]
103564951  KCNA4; potassium voltage-gated channel subfamily A member 4 [KO:K04877]
103546472  KCNK3; potassium two pore domain channel subfamily K member 3 [KO:K04914]
103564902  LDLR; low density lipoprotein receptor [KO:K12473]
103560375  SCARB1; scavenger receptor class B member 1 [KO:K13885]
103567309  cholesterol side-chain cleavage enzyme, mitochondrial [KO:K00498] [EC:1.14.15.6]
103548379  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase [KO:K00070] [EC:1.1.1.145 5.3.3.1]
103563302  steroid 21-hydroxylase [KO:K00513] [EC:1.14.14.16]
103555158  fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
103559025  FH; fumarate hydratase [KO:K01679] [EC:4.2.1.2]
103552200  WNT1; Wnt family member 1 [KO:K03209]
103550603  WNT2; Wnt family member 2 [KO:K00182]
103541803  WNT2B; Wnt family member 2B [KO:K00182]
103552917  WNT3; Wnt family member 3 [KO:K00312]
103565876  WNT3A; Wnt family member 3A [KO:K00312]
103558485  WNT4; Wnt family member 4 [KO:K00408]
103565849  WNT5A; Wnt family member 5A [KO:K00444]
103555816  WNT5B; Wnt family member 5B [KO:K00444]
103543266  protein Wnt-5b-like [KO:K00444]
103567913  WNT6; Wnt family member 6 [KO:K00445]
103556791  WNT7A; Wnt family member 7A [KO:K00572]
103558099  WNT7B; Wnt family member 7B [KO:K00572]
103563555  WNT8A; Wnt family member 8A [KO:K00714]
103562517  WNT8B; Wnt family member 8B [KO:K00714]
103554698  WNT9B; Wnt family member 9B [KO:K01064]
103565875  WNT9A; Wnt family member 9A [KO:K01064]
103552222  WNT10B; Wnt family member 10B [KO:K01357]
103567916  WNT10A; Wnt family member 10A [KO:K01357]
103548228  WNT11; Wnt family member 11 [KO:K01384]
103564131  WNT16; Wnt family member 16 [KO:K01558]
103560190  FZD1; frizzled class receptor 1 [KO:K02432]
103567476  FZD7; frizzled class receptor 7 [KO:K02432]
103551209  FZD2; frizzled class receptor 2 [KO:K02235]
103567492  FZD3; frizzled class receptor 3 [KO:K02329]
103564599  FZD4; frizzled class receptor 4 [KO:K02354]
103548916  FZD5; frizzled class receptor 5 [KO:K02375]
103565119  FZD6; frizzled class receptor 6 [KO:K02376]
103548763  FZD10; frizzled class receptor 10 [KO:K02842]
103566121  FZD9; frizzled class receptor 9 [KO:K02842]
103554749  DVL3; dishevelled segment polarity protein 3 [KO:K02353]
103557742  DVL2; dishevelled segment polarity protein 2 [KO:K02353]
103542807  DVL1; dishevelled segment polarity protein 1 [KO:K02353]
103547424  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]
103564115  AXIN1; axin 1 [KO:K02157]
103553492  AXIN2; axin 2 [KO:K04385]
103552888  CTNNB1; catenin beta 1 [KO:K02105]
103561228  APC; APC, WNT signaling pathway regulator [KO:K02085]
103543120  TCF7; transcription factor 7 (T-cell specific, HMG-box) [KO:K02620]
103548276  TCF7L1; transcription factor 7 like 1 [KO:K04490]
103564289  TCF7L2; transcription factor 7 like 2 [KO:K04491]
103557035  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]
Compound
C00020  AMP
C00076  Calcium cation
C00187  Cholesterol
C00238  Potassium cation
C00410  Progesterone
C00575  3',5'-Cyclic AMP
C00735  Cortisol
C01176  17alpha-Hydroxyprogesterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01953  Pregnenolone
C05138  17alpha-Hydroxypregnenolone
C05488  11-Deoxycortisol
C07557  2,3,7,8-Tetrachlorodibenzodioxin
Reference
  Authors
Lacroix A, Feelders RA, Stratakis CA, Nieman LK
  Title
Cushing's syndrome.
  Journal
Lancet 386:913-27 (2015)
DOI:10.1016/S0140-6736(14)61375-1
Reference
  Authors
Xiong Q, Ge W
  Title
Gene mutations in Cushing's disease.
  Journal
Biomed Rep 5:277-282 (2016)
DOI:10.3892/br.2016.729
Reference
  Authors
Fukuoka H, Takahashi Y
  Title
The role of genetic and epigenetic changes in pituitary tumorigenesis.
  Journal
Neurol Med Chir (Tokyo) 54 Suppl 3:943-57 (2014)
DOI:10.2176/nmc.suppl.2014-3
Reference
  Authors
Quereda V, Malumbres M
  Title
Cell cycle control of pituitary development and disease.
  Journal
J Mol Endocrinol 42:75-86 (2009)
DOI:10.1677/JME-08-0146
Reference
  Authors
Caimari F, Korbonits M
  Title
Novel Genetic Causes of Pituitary Adenomas.
  Journal
Clin Cancer Res 22:5030-5042 (2016)
DOI:10.1158/1078-0432.CCR-16-0452
Reference
  Authors
Lecoq AL, Kamenicky P, Guiochon-Mantel A, Chanson P
  Title
Genetic mutations in sporadic pituitary adenomas--what to screen for?
  Journal
Nat Rev Endocrinol 11:43-54 (2015)
DOI:10.1038/nrendo.2014.181
Reference
  Authors
Hannah-Shmouni F, Faucz FR, Stratakis CA
  Title
Alterations of Phosphodiesterases in Adrenocortical Tumors.
  Journal
Front Endocrinol (Lausanne) 7:111 (2016)
DOI:10.3389/fendo.2016.00111
Reference
  Authors
Melmed S
  Title
Pathogenesis of pituitary tumors.
  Journal
Nat Rev Endocrinol 7:257-66 (2011)
DOI:10.1038/nrendo.2011.40
Reference
  Authors
Daly AF, Tichomirowa MA, Beckers A
  Title
Genetic, molecular and clinical features of familial isolated pituitary adenomas.
  Journal
Horm Res 71 Suppl 2:116-22 (2009)
DOI:10.1159/000192448
Reference
  Authors
Albani A, Theodoropoulou M, Reincke M
  Title
Genetics of Cushing's disease.
  Journal
Clin Endocrinol (Oxf) 88:3-12 (2018)
DOI:10.1111/cen.13457
Reference
  Authors
Duan K, Hernandez KG, Mete O
  Title
Clinicopathological correlates of adrenal Cushing's syndrome.
  Journal
Postgrad Med J 91:331-42 (2015)
DOI:10.1136/postgradmedj-2014-202612rep
Reference
  Authors
Drougat L, Espiard S, Bertherat J
  Title
Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?
  Journal
Eur J Endocrinol 173:M121-31 (2015)
DOI:10.1530/EJE-15-0532
Reference
  Authors
Stratakis CA, Boikos SA
  Title
Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias.
  Journal
Nat Clin Pract Endocrinol Metab 3:748-57 (2007)
DOI:10.1038/ncpendmet0648
Reference
  Authors
Refojo D, Holsboer F
  Title
CRH signaling. Molecular specificity for drug targeting in the CNS.
  Journal
Ann N Y Acad Sci 1179:106-19 (2009)
DOI:10.1111/j.1749-6632.2009.04983.x
Reference
  Authors
Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E
  Title
Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.
  Journal
Mol Endocrinol 16:1638-51 (2002)
DOI:10.1210/mend.16.7.0863
Reference
  Authors
Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J
  Title
Cushing's syndrome variants secondary to aberrant hormone receptors.
  Journal
Trends Endocrinol Metab 15:375-82 (2004)
DOI:10.1016/j.tem.2004.08.007
Reference
  Authors
Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, Tanaka K, Wieland T, Graf E, Saeger W, Ronchi CL, Allolio B, Buchfelder M, Strom TM, Fassnacht M, Komada M
  Title
Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
  Journal
Nat Genet 47:31-8 (2015)
DOI:10.1038/ng.3166
Reference
  Authors
Kaiser UB
  Title
Cushing's disease: towards precision medicine.
  Journal
Cell Res 25:649-50 (2015)
DOI:10.1038/cr.2015.53
Reference
  Authors
Uzilov AV, Cheesman KC, Fink MY, Newman LC, Pandya C, Lalazar Y, Hefti M, Fowkes M, Deikus G, Lau CY, Moe AS, Kinoshita Y, Kasai Y, Zweig M, Gupta A, Starcevic D, Mahajan M, Schadt EE, Post KD, Donovan MJ, Sebra R, Chen R, Geer EB
  Title
Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.
  Journal
Cold Spring Harb Mol Case Stud 3:a001602 (2017)
DOI:10.1101/mcs.a001602
Reference
  Authors
Huang C, Shi Y, Zhao Y
  Title
USP8 mutation in Cushing's disease.
  Journal
Oncotarget 6:18240-1 (2015)
DOI:10.18632/oncotarget.4856
Reference
  Authors
Theodoropoulou M, Reincke M, Fassnacht M, Komada M
  Title
Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.
  Journal
Eur J Endocrinol 173:M73-83 (2015)
DOI:10.1530/EJE-15-0320
Reference
  Authors
Yu L, Zhang J, Guo X, Chen X, He Z, He Q
  Title
ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.
  Journal
PLoS One 13:e0191602 (2018)
DOI:10.1371/journal.pone.0191602
Reference
  Authors
Wu X, Hua X
  Title
Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.
  Journal
Curr Mol Med 8:805-15 (2008)
DOI:10.2174/156652408786733702
Reference
  Authors
Ozfirat Z, Korbonits M
  Title
AIP gene and familial isolated pituitary adenomas.
  Journal
Mol Cell Endocrinol 326:71-9 (2010)
DOI:10.1016/j.mce.2010.05.001
Related
pathway
epz00020  Citrate cycle (TCA cycle)
epz00140  Steroid hormone biosynthesis
epz04020  Calcium signaling pathway
epz04024  cAMP signaling pathway
epz04110  Cell cycle
epz04310  Wnt signaling pathway
epz04927  Cortisol synthesis and secretion
epz04960  Aldosterone-regulated sodium reabsorption
KO pathway
ko04934   
LinkDB

DBGET integrated database retrieval system